Ramez Ghanbari

NPI: 1124479332
Total Payments
$1,061
2024 Payments
$788.61
Companies
9
Transactions
40

Payment Breakdown by Category

Food & Beverage$973.65 (91.8%)
Education$87.49 (8.2%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $973.65 39 91.8%
Education $87.49 1 8.2%

Top Paying Companies

Company Total Records Latest Year
Teva Pharmaceuticals USA, Inc. $434.78 12 $0 (2024)
Lundbeck LLC $193.62 8 $0 (2024)
Neurocrine Biosciences, Inc. $110.34 4 $0 (2024)
Otsuka America Pharmaceutical, Inc. $96.81 4 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $80.58 5 $0 (2024)
Vanda Pharmaceuticals Inc. $64.74 3 $0 (2023)
Supernus Pharmaceuticals, Inc. $38.05 2 $0 (2023)
OWP Pharmaceuticals, Inc. $22.91 1 $0 (2022)
Janssen Pharmaceuticals, Inc $19.31 1 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $788.61 27 Teva Pharmaceuticals USA, Inc. ($382.35)
2023 $170.55 8 Teva Pharmaceuticals USA, Inc. ($52.43)
2022 $101.98 5 Vanda Pharmaceuticals Inc. ($43.24)

All Payment Transactions

40 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
12/04/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $17.42 General
Category: PSYCHIATRY
11/19/2024 Takeda Pharmaceuticals U.S.A., Inc. TRINTELLIX (Drug) Food and Beverage In-kind items and services $14.54 General
Category: NEUROSCIENCE
11/13/2024 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $17.87 General
Category: Central Nervous System
11/12/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $38.72 General
Category: Neuropsychiatry
10/16/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $26.36 General
Category: PSYCHIATRY
10/08/2024 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $20.41 General
Category: Central Nervous System
09/24/2024 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $21.46 General
Category: Central Nervous System
08/07/2024 Teva Pharmaceuticals USA, Inc. Education In-kind items and services $87.49 General
08/07/2024 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $26.04 General
Category: Central Nervous System
06/19/2024 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $30.72 General
Category: Central Nervous System
06/11/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $31.57 General
Category: Neuropsychiatry
06/05/2024 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $102.76 General
Category: Central Nervous System
06/05/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $23.72 General
Category: PSYCHIATRY
05/16/2024 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $28.43 General
Category: Central Nervous System
05/15/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $29.74 General
Category: PSYCHIATRY
05/02/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $26.29 General
Category: PSYCHIATRY
04/30/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $21.96 General
Category: PSYCHIATRY
04/23/2024 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $24.12 General
Category: Central Nervous System
04/11/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $27.83 General
Category: PSYCHIATRY
04/02/2024 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $23.05 General
Category: Central Nervous System
03/13/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $24.94 General
Category: PSYCHIATRY
03/13/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $16.63 General
Category: PSYCHIATRY
02/21/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $14.59 General
Category: Neuropsychiatry
02/14/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $25.63 General
Category: PSYCHIATRY
02/12/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $27.30 General
Category: PSYCHIATRY

About Ramez Ghanbari

Ramez Ghanbari is a Psychiatry healthcare provider based in Riverside, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2016. The National Provider Identifier (NPI) number assigned to this provider is 1124479332.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ramez Ghanbari has received a total of $1,061 in payments from pharmaceutical and medical device companies, with $788.61 received in 2024. These payments were reported across 40 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($973.65).

Practice Information

  • Specialty Psychiatry
  • Location Riverside, CA
  • Active Since 06/29/2016
  • Last Updated 07/29/2021
  • Taxonomy Code 2084P0800X
  • Entity Type Individual
  • NPI Number 1124479332

Products in Payments

  • Austedo XR (Drug) $347.29
  • REXULTI (Drug) $290.43
  • INGREZZA (Drug) $110.34
  • TRINTELLIX (Drug) $80.58
  • HETLIOZ (Drug) $64.74
  • QELBREE (Drug) $38.05
  • SUBVENITE (Drug) $22.91
  • SPRAVATO (Drug) $19.31

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Psychiatry Doctors in Riverside